Phase II Trial of Pegylated Liposomal Doxorubicin-Cyclophosphamide Combination as First-Line Chemotherapy in Older Metastatic Breast Cancer Patients

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

Herpes Infections in Breast Cancer Patients Treated with Adjuvant Chemotherapy

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 164-167

Karger

Access to resources Recommend Favorite

Testing a novel account of the dissociation between self‐reported memory problems and memory performance in chemotherapy‐treated breast cancer survivors

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 27, Iss. 1, 2018-01 ,pp. : 171-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term cardiac safety and outcomes of dose‐dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 3943-3951

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy with Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil in Locally Advanced Breast Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 2, 2005-01 ,pp. : 81-85

Karger

Access to resources Recommend Favorite